Markets:

Overview

News

Currencies

International

Treasuries

VivoPower PLC - Ordinary Shares (NQ:VIVO)

2.280 -0.060 (-2.56%)

Streaming Delayed Price Updated: 2:01 PM EDT, Mar 24, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about VivoPower PLC - Ordinary Shares

< Previous 1 2 3 4 Next >

DoubleVerify To Join S&P SmallCap 600 On January 31 ↗

January 26, 2023

Via Benzinga

Meridian Bioscience's Return On Capital Employed Overview ↗

December 29, 2022

Via Benzinga

Cannabis Stock Gainers And Losers From December 12, 2022 ↗

December 12, 2022

Via Benzinga

4 Stocks That Can Turn $100,000 Into $500,000 by the Time You Retire ↗

October 07, 2022

This quartet of stocks has plenty of growth ahead and is already profitable.

Via The Motley Fool

Silk Road Medical Stock Scores Relative Strength Rating Upgrade ↗

September 28, 2022

Silk Road Medical sees its Relative Strength Rating reach the elite 90-plus level.

Via Investor's Business Daily

Penumbra Stock Hits 80-Plus Relative Strength Rating Benchmark ↗

September 26, 2022

Penumbra stock cleared a key 80-plus relative strength benchmark Monday, with a jump to 87 from 79 on Friday.

Via Investor's Business Daily

Meridian Bioscience To Be Acquired By SD Biosensor, SJL Partners - Read For How Much ↗

July 07, 2022

Via Benzinga

Looking Into Meridian Bioscience's Return On Capital Employed ↗

August 26, 2022

Meridian Bioscience (NASDAQ:VIVO) brought in sales totaling $67.77 million during Q3 according to data provided by Benzinga Pro. However, earnings decreased 125.52%, resulting in a loss of $7.34...

Via Benzinga

Meridian Bioscience: Q3 Earnings Insights ↗

August 05, 2022

Meridian Bioscience (NASDAQ:VIVO) reported its Q3 earnings results on Friday, August 5, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

Earnings Scheduled For August 5, 2022 ↗

August 05, 2022

Companies Reporting Before The Bell • Reservoir Media (NASDAQ:RSVR) is projected to report quarterly loss at $0.05 per share on revenue of $18.19 million.

Via Benzinga

Preview: Meridian Bioscience's Earnings ↗

August 04, 2022

Meridian Bioscience (NASDAQ:VIVO) is set to give its latest quarterly earnings report on Friday, 2022-08-05. Here's what investors need to know before the announcement. Analysts estimate that Meridian...

Via Benzinga

Recap Of Friday's Biotech Catalysts - End of The Day Summary ↗

July 29, 2022

Via Benzinga

Silk Road Medical Stock Clears Key Benchmark, Hitting 90-Plus RS Rating ↗

July 22, 2022

Silk Road Medical stock saw a welcome improvement to its Relative Strength (RS) Rating on Friday, with an upgrade from 69 to 90.

Via Investor's Business Daily

Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2022 ↗

July 08, 2022

Via Benzinga

MERIDIAN BIOSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Meridian Bioscience, Inc. - VIVO

July 07, 2022

From Kahn Swick & Foti, LLC

Via Business Wire

Dear AMC Stock Fans, Mark Your Calendars for Aug. 4 ↗

July 07, 2022

AMC Entertainment (AMC) stock is in the news today as investors in the theater company prepare for a potential catalyst coming next month!

Via InvestorPlace

Meridian Biosciences (VIVO) Stock Trending on $1.5 Billion Buyout Agreement ↗

July 07, 2022

VIVO stock is a hot topic on Wall Street today, not just because Meridian Biosciences released a fiscal update, but also due to takeover news.

Via InvestorPlace

VIVO Stock Alert: Halper Sadeh LLP Is Investigating Whether the Sale of Meridian Bioscience, Inc. Is Fair to Shareholders

July 07, 2022

From Halper Sadeh LLP

Via Business Wire

Cannabis Stock Gainers And Losers From July 6, 2022 ↗

July 06, 2022

GAINERS: Tilray Brands (NASDAQ:TLRY) shares closed up 8.02% at $3.50

Via Benzinga

Marijuana Stock Movers For June 30, 2022 ↗

June 30, 2022

GAINERS: Marrone Bio Innovations (NASDAQ:MBII) shares closed up 6.42% at $1.16

Via Benzinga

EXCLUSIVE: Has Biotech Bottomed? NYSE Executive Floor Director Says Biogen And These 3 Stocks Look Poised To Outperform ↗

June 30, 2022

Markets continue to trend lower amid rising inflation and Fed uncertainty, but one New York Stock Exchange floor director says the bottom may be in for a couple of beaten-down sectors.

Via Benzinga

Cannabis Stock Movers For June 29, 2022 ↗

June 29, 2022

GAINERS: Cansortium (OTC:CNTMF) shares closed up 4.07% at $0.17

Via Benzinga

Cannabis Stock Movers For June 28, 2022 ↗

June 28, 2022

GAINERS: Item 9 Labs (OTC:INLB) shares closed up 16.35% at $0.79

Via Benzinga

Cannabis Stock Gainers And Losers From June 27, 2022 ↗

June 27, 2022

GAINERS: MGC Pharmaceuticals (OTC:MGCLF) shares closed up 46.08% at $0.02

Via Benzinga

Cannabis Stock Gainers And Losers From June 17, 2022 ↗

June 17, 2022

GAINERS: Origin Agritech (NASDAQ:SEED) shares closed up 10.10% at $7.63

Via Benzinga

Cannabis Stock Movers For June 9, 2022 ↗

June 09, 2022

GAINERS: Zynerba Pharmaceuticals (NASDAQ:ZYNE) shares closed up 35.09% at $1.29 LOSERS:

Via Benzinga

Bearish Sentiment Across The Cannabis Space - Check Full Movers For June 8, 2022 ↗

June 08, 2022

GAINERS: Cansortium (OTC:CNTMF) shares closed up 12.00% at $0.22

Via Benzinga

Cannabis Stock Movers For June 6, 2022 ↗

June 06, 2022

GAINERS: Leviathan Natural Prods (OTC:LVCNF) shares closed up 17.12% at $0.87

Via Benzinga

Looking Into Meridian Bioscience's Return On Capital Employed ↗

June 01, 2022

According to Benzinga Pro, during Q2, Meridian Bioscience (NASDAQ:VIVO) earned $28.75 million, a 87.43% increase from the preceding quarter. Meridian Bioscience also posted a total of $111.23 million...

Via Benzinga

This Company Looks To Make Its Value-Added Technologies Benefit Smartphone Consumers In China — Then The World? ↗

May 20, 2022

Photo by Deep Advani on Unsplash This post contains sponsored advertising content. This content is for informational purposes only and is not intended to be investing advice.

Via Benzinga

< Previous 1 2 3 4 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.